Philips Gets FDA Clearance for Ultrasound 5000 Compact Series


Offering the benefits of real-time collaboration and integrated connectivity, the portable ultrasound device may be utilized in a variety of clinical settings ranging from cardiology to obstetrics and gynecology.

The Philips Ultrasound 5000 Compact Series, which reportedly facilitates real-time collaboration and streamlined workflows, has garnered 510(k) clearance from the Food and Drug Administration (FDA).

Philips noted the portable device provides a combination of enhanced image quality and remote consultation capability (via Philips Ultrasound Collaboration Live tele-ultrasound) that facilitates clinical decision support with mobile efficiency. In addition to general imaging and utility in the obstetrics and gynecology fields, Philips said the Ultrasound 5000 Compact Series enables timely assessments in cardiology and point-of-care ultrasonography.

“Globally, clinicians are faced with increasing pressures to deliver higher patient throughput for quick, confident diagnoses via ultrasound exams while receiving more and more requests to perform rapid ultrasound exams at the bedside,” noted Matthijs Groot Wassink, the general manager of Point-of-Care Ultrasound at Philips. “Until now, portable ultrasound systems have typically meant decreased performance, lack of advanced features, and lower grade image quality. With this clearance for our next-generation portable Philips Ultrasound 5000 Compact Series, clinicians now have the ability to make quicker and more confident diagnoses.”

In order to facilitate consistency and efficiency with use of the Ultrasound 5000 Compact Series, Philips said the new portable device offers the same features, touch screens and user interfaces as the company’s EPIQ and Affiniti ultrasound systems.

Related Videos
Radiology Challenges with Breast Cancer Screening in Women with Breast Implants
Related Content
© 2023 MJH Life Sciences

All rights reserved.